Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Institutional Money Flowing Into Liveramp Holdings Ramp Stock Price At 25.70 Down 3.37 20260410 Daily Market Overview Dow Falls 0.54 Sp 500 Dips Nasdaq Posts 0.28 Gain 20260410 What Does Insider Activity Suggest For Nuveen Nmco Stock Price At 10.63 Down 0.28 20260408 Is Cal Resource Crc Stock Good For Long Term Price At 67.30 Down 0.62 20260406 Is Picard Medical Pmi Stock Safe To Buy Now Price At 1.02 Down 1.92 20260408 SLXNW Silexion reports no quarterly revenue as therapeutics pipeline advances CEO signals strategic focus on clinical milestones ahead The critical factors shaping Centene CNC future Flirts with Support 20260507 Genius GNS Stock Why Operational Efficiency Technical Strength 20260418 Is Maximus MMS stock exposed to downside risk Stuck 20260418 Phunware PHUN Stock Valuation Analysis Phunware logs 201 EPS beat no Q4 revenue data MFC Manulife reports 46 percent Q4 2025 EPS beat shares rise slightly amid sharp year over year revenue decline NEWTO NewtekOne earnings preview fixed rate senior notes draw investor attention ahead of quarterly results ICICI Bank IBN Stock Sell Signals Marginal Gain 20260420 RCON Recon EPS crushes estimates by 52 but shares slide 3 amid broader sector weakness CVS Health CVS Valuation Disparity and Bearish Downside Risks Amid Mixed Share Price Momentum Renasant Corporation RNST Stock Is It Gaining Market Strength Q1 2026 Earnings Beat Estimates Is Hancock HWCPZ stock building strength Q1 2026 Better Than Expected TBMCR Trailblazer publishes latest quarterly earnings investors seek clarity on planned merger target timelines and terms Johnson Johnson XLV Consensus Bullish Sentiment Holds Following Q1 Earnings Beat And Raised 2026 Guidance Immatics NV IMTX Q1 2026 Earnings Miss Sparks Concern Trumps Latest Financial Disclosure Reveals Unexpected Crypto Stock Investments Court Rulings Dim Democrats House Takeover Odds Kalshi Traders React Zions ZION Reports Strong Q1 2026 Revenue NA EPS Beats Actinium ATNM Q1 2026 Earnings 018 EPS Surges Past 024 Estimates AngloGold AU Rallies 132 as Bulls Target 9813 20260518 Revolution RVMDW Slides 890 as Selling Pressure Mounts 20260517 Tech Stocks Are Getting Cheaper Is the AI Hype Cooling Down Okeanis ECO Gained 383 Can It Break 5927 20260520 Minnesota Becomes First State to Pass Felony Ban on Prediction Markets DLocal DLO Up 114 Is There More Room to Run 20260520 Artesian ARTNA Crushes Q3 2025 Estimates EPS 068 Tops Views Mercury Fintech Valuation Hits 52 Billion After Funding Surge Up 49 in 14 Months Wells Fargo Upgrades Automatic Data Processing to Equal Weight Sets 214 Price Target Pet Supplies Retailer Files Chapter 11 Bankruptcy Amid Sector Consolidation Saudi Arabias Vision 2030 Spending Spree Hits Fiscal Constraints Horchata Emerges as a Growing Trend in the UK Beverage Sector PureCycle Technologies Inc Unit PCTTU Q1 2026 Earnings NarrowerthanExpected Loss Amid PreRevenue Phase LiqTech International Inc LIQT Q1 2026 Earnings EPS Misses Estimates Amid Persistent Operational Headwinds NeoGenomics NEO Q1 2026 Earnings EPS Beats Estimates by 389 Stock Gains ZNTL Q1 2026 Earnings PreRevenue Biotech Posts WiderthanExpected Net Loss KALU Q1 2026 Earnings Massive EPS Surprise Drives Share Uptick DSL Edges Higher Amid Modest Gains Holding Above Key Support Voya Emerging Markets High Income Dividend Equity Fund IHD Edges Higher as Investors Seek Yield Medalist Diversified Inc MDRR Declines Sharply Testing Key Support Levels NSPR Q1 2026 Earnings Loss Narrower Than Expected as InspireMD Advances Commercial Pipeline LBRDA Q3 2025 Earnings Strong EPS Beat Boosts Investor Sentiment BayCom Corp BCML Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Uptick Wall Street Edges Higher as Mideast Peace Hopes Boost Investor Sentiment Heartland Express Q1 2026 Earnings EPS Loss Narrows Beats Consensus by Nearly 50 Vivani Medical Q1 2026 Earnings Slight EPS Beat Fails to Stem Stock Decline as PreRevenue Biotech Navigates Development Pipeline